drugset / Trial / NCT01033370

A Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT)

NCT01033370 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study is a single center, non-randomized, open-label, pilot efficacy and safety study evaluating the ability of clevidipine IV antihypertensive to rapidly control elevated blood pressure (BP) in the setting of an acute aortic emergencies (aneurysm, dissection or other aortic disease).

Timeline

Start
2009-11
Primary completion
2012-08
Completion
2012-08

Outcome

Outcome not reported

Stopped (Business): “Project lacked funding.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule 2 mg Intravenous

Indications